BDX Q3 2021 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$59B

Q3 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.6B+19.5% YoY

Gross Profit

$2.0B42.5% margin

Operating Income

$492M10.7% margin

Net Income

$525M11.4% margin

EPS (Diluted)

$1.72

QoQ Revenue Growth

-6.1%

Cash Flow

Operating Cash Flow

$975M

Free Cash Flow

$708M

Stock-Based Comp.

$51M

Balance Sheet

Total Assets

$54.3B

Total Liabilities

$30.2B

Stockholders' Equity

$24.1B

Cash & Equivalents

$3.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.6B	$3.9B	+19.5%
Gross Profit	$2.0B	$1.7B	+18.0%
Operating Income	$492M	$358M	+37.4%
Net Income	$525M	$286M	+83.6%

Revenue Segments

Medical

$2.4B49%

Life Sciences

$1.4B29%

Interventional

$1.1B22%

Geographic Segments

UNITED STATES

$2.6B53%

Non-US

$2.3B47%